Kevin J. Croce
MD, PhD
​
Dr. Kevin J. Croce is an interventional cardiologist and the director of the Chronic Total Occlusion Complex Percutaneous Coronary Intervention Program at Brigham and Women’s Hospital (BWH). He is an assistant professor of medicine at Harvard Medical School (HMS) who also directs the BWH Translational Discovery Laboratory which is a centralized research facility that uses state-of-the-art technology to perform preclinical testing of promising therapies and medical devices. Dr. Croce received his medical and Ph.D. degrees from Tufts University School of Medicine. He completed an internal medicine residency, a cardiology fellowship and an interventional cardiology fellowship at BWH. Dr. Croce is board certified in internal medicine, cardiovascular disease and interventional cardiology. His clinical interests include advanced treatments for obstructive coronary artery disease (CAD), and optimization of antithrombotic and antiplatelet pharmacotherapy. The author of over 50 peer-reviewed publications, Dr. Croce’s research focuses on understanding the molecular pathobiology of atherothrombotic (CAD) and on identifying new targets for CAD treatment. His research has received support from the National Institutes of Health.
Jon George
MD
​
Dr. Jon C. George, MD is a highly regarded Interventional Cardiologist recognized for his significant contributions to the advancement of complex coronary and peripheral vascular interventions. Over the course of his career, Dr. George has played a pivotal role in shaping contemporary interventional practice through clinical innovation, research, education, and early evaluation of novel cardiovascular devices. Dr. George has extensive experience in the treatment of complex coronary artery disease, including chronic total occlusions (CTOs), calcified lesions, and high-risk percutaneous coronary interventions. He has been at the forefront of adopting and refining advanced interventional techniques and has actively contributed to the development and clinical assessment of new catheter-based technologies aimed at improving procedural success and patient outcomes. A prolific academic contributor, Dr. George has authored over 100 peer-reviewed publications, numerous book chapters, and has served as editor of the Evidence-Based Guide to Interventional Cardiology and Endovascular Medicine. His research spans clinical trials, device innovation, imaging-guided interventions, and outcomes-based studies, reflecting a strong commitment to evidence-driven progress in the field. Dr. George has also been deeply involved in first-in-human and early-feasibility studies, working closely with industry and academic partners to translate emerging technologies from concept to clinical practice. His ability to bridge clinical need with device design has made him a trusted advisor in cardiovascular innovation.